2,778 followers
RT @NatRevClinOncol: The FDA has approved pembrolizumab as a 1st-line treatment of metastatic or unresectable recurrent HNSCC, either with…
RT @NatRevClinOncol: The FDA has approved pembrolizumab as a 1st-line treatment of metastatic or unresectable recurrent HNSCC, either with…
RT @NatRevClinOncol: The FDA has approved pembrolizumab as a 1st-line treatment of metastatic or unresectable recurrent HNSCC, either with…
RT @BertrandBio: The changing therapeutic landscape of head and neck cancer #hncsm https://t.co/m7ZgS1yot1 https://t.co/KoDAkisUIC
RT @BertrandBio: The changing therapeutic landscape of head and neck cancer #hncsm https://t.co/m7ZgS1yot1 https://t.co/KoDAkisUIC